财政激励对需要胰岛素治疗的糖尿病患者妊娠期间葡萄糖自我监测依从性的影响:一项随机临床试验。
The Effect of Financial Incentives on Adherence to Glucose Self-Monitoring during Pregnancy among Patients with Insulin-Requiring Diabetes: A Randomized Clinical Trial.
机构信息
Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota.
Division of Molecular Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
出版信息
Am J Perinatol. 2024 May;41(S 01):e259-e266. doi: 10.1055/a-1889-7765. Epub 2022 Jul 1.
OBJECTIVE
Glucose self-monitoring is critical for the management of diabetes in pregnancy, and increased adherence to testing is associated with improved obstetrical outcomes. Incentives have been shown to improve adherence to diabetes self-management. We hypothesized that use of financial incentives in pregnancies complicated by diabetes would improve adherence to glucose self-monitoring.
STUDY DESIGN
We conducted a single center, randomized clinical trial from May 2016 to July 2019. In total, 130 pregnant patients, <29 weeks with insulin requiring diabetes, were recruited. Participants were randomized in a 1:1:1 ratio to one of three payment groups: control, positive incentive, and loss aversion. The control group received $25 upon enrollment. The positive incentive group received 10 cents/test, and the loss aversion group received $100 for >95% adherence and "lost" payment for decreasing adherence. The primary outcome was percent adherence to recommended glucose self-monitoring where adherence was reliably quantified using a cellular-enabled glucometer. Adherence, calculated as the number of tests per day divided by the number of recommended tests per day×100%, was averaged from time of enrollment until admission for delivery.
RESULTS
We enrolled 130 participants and the 117 participants included in the final analysis had similar baseline characteristics across the three groups. Average adherence rates in the loss aversion, control and positive incentive groups were 69% (SE=5.12), 57% (SE = 4.60), and 58% (SE=3.75), respectively (=0.099). The loss aversion group received an average of $50 compared with $38 (positive incentive) and $25 (control).
CONCLUSION
In this randomized clinical trial, loss aversion incentives tended toward higher adherence to glucose self-monitoring among patients whose pregnancies were complicated by diabetes, though did not reach statistical significance. Further studies are needed to determine whether use of incentives improve maternal and neonatal outcomes.
KEY POINTS
· Self-glucose monitoring is a critical part of diabetes management in pregnancy.. · Loss aversion financial incentives may increase adherence to glucose self-monitoring in pregnancy.. · The impact of testing incentives on maternal and neonatal outcomes requires further investigation..
目的
血糖自我监测对妊娠糖尿病的管理至关重要,增加检测依从性与改善产科结局相关。激励措施已被证明可提高糖尿病自我管理的依从性。我们假设在糖尿病合并妊娠中使用经济激励措施会提高对血糖自我监测的依从性。
研究设计
我们于 2016 年 5 月至 2019 年 7 月进行了一项单中心、随机临床试验。共招募了 130 名 29 周以下需要胰岛素治疗的糖尿病孕妇。参与者按照 1:1:1 的比例随机分为三组:对照组、正激励组和损失厌恶组。对照组在入组时获得 25 美元。正激励组每检测一次获得 10 美分,损失厌恶组如果 95%以上的检测依从率获得 100 美元,检测依从率下降则“损失”支付。主要结局是推荐的血糖自我监测的依从率,通过使用支持蜂窝网络的血糖仪可靠地量化依从率。从入组开始到入院分娩,每天的检测次数除以每天推荐的检测次数×100%,作为依从率的平均值。
结果
我们共入组了 130 名参与者,最终分析的 117 名参与者在三组之间具有相似的基线特征。损失厌恶组、对照组和正激励组的平均依从率分别为 69%(SE=5.12)、57%(SE=4.60)和 58%(SE=3.75)(=0.099)。损失厌恶组平均获得 50 美元,而正激励组和对照组分别获得 38 美元和 25 美元。
结论
在这项随机临床试验中,损失厌恶激励措施在糖尿病合并妊娠患者中趋向于提高血糖自我监测的依从性,但未达到统计学意义。需要进一步的研究来确定激励措施是否可以改善母婴结局。
重点
·自我血糖监测是妊娠糖尿病管理的关键部分。·损失厌恶财务激励措施可能会增加妊娠期间的血糖自我监测依从性。·测试激励对母婴结局的影响需要进一步研究。